HeartFlow Analyst Price Targets

Wall Street analyst price targets and consensus rating for HeartFlow (HTFL).

Price Target Range — 6 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Hold

Consensus RatingBuy# Analysts9Avg. Consensus PT$46Upside to Avg. PT-18.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 20, 2026	Piper Sandler	Matt OBrien	PT Raise	Overweight	$45→$64
Sep 22, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$45→$56
Sep 9, 2026	UBS	Doug Schenkel	Initiate	Neutral	$55
Aug 14, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$37→$45
Aug 14, 2026	Morgan Stanley	Patrick Wood	PT Raise	Equal-Weight	$35→$40
Aug 14, 2026	Stifel	Rick Wise	PT Raise	Buy	$40→$45
Aug 14, 2026	Piper Sandler	Matt OBrien	PT Raise	Overweight	$38→$45
Aug 14, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$35→$45
Aug 14, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$37→$39
Jul 31, 2026	Baird	David Rescott	Initiate	Outperform	$34
Jul 1, 2026	Freedom Capital Markets	Gene Mannheimer	Initiate	Buy	$37
May 15, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$43→$37
May 15, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$35→$37
May 4, 2026	William Blair	Brandon Vazquez	Initiate	Outperform	—
Mar 19, 2026	JP Morgan	Robbie Marcus	PT Cut	Overweight	$40→$35
Mar 19, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$40→$43
Mar 19, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$38→$35
Mar 9, 2026	Canaccord Genuity	William Plovanic	Maintained	Buy	$40
Jan 28, 2026	Wells Fargo	Larry Biegelsen	Initiate	Overweight	$38
Nov 13, 2025	Canaccord Genuity	William Plovanic	PT Raise	Buy	$39→$40

Analyst Ratings News

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64

Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $45 to $64.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $45 to $56.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and announces Price Target of $55.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $37 to $45.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and raises the price target from $35 to $40.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $38 to $45.

Benzinga Newsdesk

HeartFlow Inc

뉴스

파트너 / 기고자

벤징가 글로벌

HeartFlow Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

People Also Watch

People Also Watch

HeartFlow Inc

뉴스

파트너 / 기고자

벤징가 글로벌

HeartFlow Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROPiper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64

PROCanaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PROUBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PROCanaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PROMorgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PROPiper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

People Also Watch

People Also Watch

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45